One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Clinical trial NCT02240108 · TERMINATED
Trial details
- NCT number
- NCT02240108
- Sponsor
- Bausch Health Americas, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-28
- Primary completion
- 2017-10-06
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.